Benralizumab as a steroid-sparing treatment option in eosinophilic granulomatosis with polyangiitis
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is a vasculitis associated
with significant morbidity and mortality that has historically been treated with systemic …
with significant morbidity and mortality that has historically been treated with systemic …
[引用][C] Benralizumab as a Steroid-Sparing Treatment Option in Eosinophilic Granulomatosis with Polyangiitis
VP Guntur, LA Manka, JL Denson, RM Dunn… - The Journal of Allergy …, 2021 - cir.nii.ac.jp
Benralizumab as a Steroid-Sparing Treatment Option in Eosinophilic Granulomatosis with
Polyangiitis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Polyangiitis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Benralizumab as a Steroid-Sparing Treatment Option in Eosinophilic Granulomatosis with Polyangiitis
VP Guntur, LA Manka, JL Denson… - The journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is a vasculitis associated
with significant morbidity and mortality that has historically been treated with systemic …
with significant morbidity and mortality that has historically been treated with systemic …
Benralizumab as a Steroid-Sparing Treatment Option in Eosinophilic Granulomatosis with Polyangiitis.
VP Guntur, LA Manka, JL Denson… - The Journal of Allergy …, 2020 - europepmc.org
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is a vasculitis associated
with significant morbidity and mortality that has historically been treated with systemic …
with significant morbidity and mortality that has historically been treated with systemic …
Benralizumab as a Steroid-Sparing Treatment Option in Eosinophilic Granulomatosis with Polyangiitis
VP Guntur, LA Manka, JL Denson… - The Journal of …, 2021 - jaci-inpractice.org
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is a vasculitis associated
with significant morbidity and mortality that has historically been treated with systemic …
with significant morbidity and mortality that has historically been treated with systemic …
[PDF][PDF] Benralizumab as a Steroid-Sparing Treatment Option in Eosinophilic Granulomatosis with Polyangiitis
VP Guntur, LA Manka, JL Denson, RM Dunn - 2020 - researchgate.net
BACKGROUND: Eosinophilic granulomatosis with polyangiitis (EGPA) is a vasculitis
associated with significant morbidity and mortality that has historically been treated with …
associated with significant morbidity and mortality that has historically been treated with …